快报
欢迎光临蚂蚁淘在线！ 请登录 免费注册
商品
品牌
文章
热门搜索：
快报
品牌首页 品牌新闻 品牌简介 产品中心 品牌咨询 联系我们
品牌分类
品牌咨询
联系方式
公司地址
苏州工业园区生物纳米园A4#216
联系电话
4000-520-616 / 18915418616
传真号码
0512-67156496
电子邮箱
info@ebiomall.com
公司网址
https://www.ebiomall.com
蚂蚁淘在线 / 品牌中心 / Trevigen / Trevigen/TACS•XL®DAB（二氨基联苯胺）试剂盒/4828-30-DK/30样品

Trevigen/TACS•XL®DAB（二氨基联苯胺）试剂盒/4828-30-DK/30样品

价格
￥1540.00
货号：4828-30-DK
浏览量：127
品牌：Trevigen
服务
全国联保
正品保证
正规发票
签订合同
商品描述

Description

TACS•XL® DABKitisdesignedforusewithfixedfrozenorparaffinembeddedtissuesections. AllthereagentsrequiredforthelabelinganddetectionoffragmentedDNAandtoassistintheidentificationofapoptoticmorphologiesareprovidedincludingtwopermeABIlizationreagents,labelinganddetectionreagents,stopbuffers,DABandMethylGreen counterstain aswellas TACS-Nuclease™forgeneratingpositivecontrolswithyourownsamples.

Pleaserefertoourcomponentslistingfordetails.

Catalog#4828-30-DKincludes:
CatalogNumberDescriptionQty
4800-30-01ProteinaseK1
4800-30-06Streptavidin-HRP1
4800-30-07Diaminobenzidine1
4800-30-09DABEnhancer1
4800-30-15TACS-Nuclease™1
4800-30-16TACS-Nuclease™Buffer1
4800-30-18MethylGreen1%1
4810-30-02TACS®2TdTLabelingBuffer1
4810-30-03TACS®2TdTStopBuffer1
4810-30-05TdTEnzyme1
4828-30-04B-dNTPMix1
4828-30-06anti-BrdUantibody1
4828-30-12Strep-Diluent1
4876-05-01Cytonin™1

 

Anti-YKL-40antibodyandionizingirrADIationsynergisticallyinhibittumorvascularizationandmalignancyinglioblastoma
Shao,R.,Francescone,R.,Ngernyuang,N.,Bentley,B.,Taylor,S.L.,Moral,L.,andYan,W.,Anti-YKL-40antibodyandionizingirradiationsynergisticallyinhibittumorvascularizationandmalignancyinglioblastoma41671CarcinogenesisCarcinogenesis373
Carcinogenesis,Feb2014;35:373–382
http://carcin.oxfordjournals.org/cgi/content/abstract/35/2/373

HepaticSerumAmyloidA1AggravatesTCell-mediatedHepatitisbyInducingChemokinesviaToll-likeReceptor2inMice
“YoungRaeJi,HeiJungKim,KiBeomBae,SanggyuLee,MyoungOkKim,andZaeYoungRyoo”
J.Biol.Chem.,May2015;290:12804–12811.
http://www.jbc.org/cgi/content/abstract/290/20/12804

PersistenteffectofmTORinhibitiononpreneoplasticfociprogressionandgeneexpressioninaratmodelofhepatocellularcarcinoma
HeatherFrancois-Vaughan,AdeolaO.Adebayo,KateE.Brilliant,NicolaM.A.Parry,PhilipA.Gruppuso,andJenniferA.Sanders
Carcinogenesis,Apr2016;37:408–419.
http://carcin.oxfordjournals.org/cgi/content/abstract/37/4/408

“MechaNISTicTargetofRapamycin(mTOR)InhibitionSynergizeswith
ReducedInternalRibosomeEntrySite(IRES)-mediatedTranslationof
CyclinD1andc-MYCmRNAstoTreatGlioblastoma”
“BrentHolmes,JihyeLee,KennaA.Landon,AngelicaBenavides-Serrato,TariqBashir,MichaelE.Jung,AlanLichtenstein,andJosephGera”
J.Biol.Chem.,Jul2016;291:14146–14159.
http://www.jbc.org/cgi/content/abstract/291/27/14146

Trevigen，Inc.是一家发展迅速的生物技术公司，致力于开发用于癌症研究，药物发现，遗传毒理学，再生医学和干细胞研究的产品和技术。我们提供试剂盒和试剂，用于研究DNA损伤和修复，细胞凋亡，氧化应激，癌细胞行为，3D培养和干细胞。该公司获得了美国国立卫生研究院（National Institutes of Health）多项SBIR资助。